Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.628 EUR
994.96 M EUR
14.93 B EUR
1.92 B
About Kenvue Inc.
Sector
Industry
CEO
Kirk L. Perry
Website
Headquarters
Summit
Founded
2022
ISIN
US49177J1025
FIGI
BBG01GHX8D50
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
KNVU5672490
Kenvue Inc. 5.2% 22-MAR-2063Yield to maturity
5.69%
Maturity date
Mar 22, 2063
KNVU5670795
Kenvue Inc. 5.05% 22-MAR-2053Yield to maturity
5.58%
Maturity date
Mar 22, 2053
KNVU5672577
Kenvue Inc. 5.1% 22-MAR-2043Yield to maturity
5.41%
Maturity date
Mar 22, 2043
KNVU5670790
Kenvue Inc. 4.9% 22-MAR-2033Yield to maturity
4.66%
Maturity date
Mar 22, 2033
KNVU6082284
Kenvue Inc. 4.85% 22-MAY-2032Yield to maturity
4.61%
Maturity date
May 22, 2032
KNVU5673074
Kenvue Inc. 5.35% 22-MAR-2026Yield to maturity
4.23%
Maturity date
Mar 22, 2026
KNVU5673058
Kenvue Inc. 5.05% 22-MAR-2028Yield to maturity
4.14%
Maturity date
Mar 22, 2028
KNVU5674333
Kenvue Inc. 5.0% 22-MAR-2030Yield to maturity
4.03%
Maturity date
Mar 22, 2030
See all J4D bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Kenvue, Inc. stocks are traded under the ticker J4D.
We've gathered analysts' opinions on Kenvue, Inc. future price: according to them, J4D price has a max estimate of 22.22 EUR and a min estimate of 15.38 EUR. Watch J4D chart and read a more detailed Kenvue, Inc. stock forecast: see what analysts think of Kenvue, Inc. and suggest that you do with its stocks.
Yes, you can track Kenvue, Inc. financials in yearly and quarterly reports right on TradingView.
Kenvue, Inc. is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
J4D earnings for the last quarter are 0.25 EUR per share, whereas the estimation was 0.24 EUR resulting in a 2.95% surprise. The estimated earnings for the next quarter are 0.23 EUR per share. See more details about Kenvue, Inc. earnings.
Kenvue, Inc. revenue for the last quarter amounts to 3.26 B EUR, despite the estimated figure of 3.27 B EUR. In the next quarter, revenue is expected to reach 3.27 B EUR.
J4D net income for the last quarter is 356.54 M EUR, while the quarter before that showed 297.64 M EUR of net income which accounts for 19.79% change. Track more Kenvue, Inc. financial stats to get the full picture.
Yes, J4D dividends are paid quarterly. The last dividend per share was 0.18 EUR. As of today, Dividend Yield (TTM)% is 5.01%. Tracking Kenvue, Inc. dividends might help you take more informed decisions.
Kenvue, Inc. dividend yield was 3.76% in 2024, and payout ratio reached 150.50%. The year before the numbers were 1.86% and 46.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 29, 2025, the company has 22 K employees. See our rating of the largest employees — is Kenvue, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kenvue, Inc. EBITDA is 2.77 B EUR, and current EBITDA margin is 21.18%. See more stats in Kenvue, Inc. financial statements.
Like other stocks, J4D shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kenvue, Inc. stock right from TradingView charts — choose your broker and connect to your account.